Company Analysis

Bio-Techne Corp (TECH)

Nasdaq: TECH · Biological Products, (No Diagnostic Substances) · Minneapolis, MN · filing with the SEC since 1995
Grade6.3
◀ Past 7.2● Present 7.3▶ Future 4.2

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

107 patents granted to the 11 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Bio-Techne Corp’s names, not what it holds today.

Patents granted
107
107 utility, 1976 to Dec 31, 2025
Granted in 2025
5
Against 9 in 2024 and 6 in 2023
Applications published
165
10 of them in 2025
Names they are printed under
11
a subsidiary, its own name, a former name
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Measurement13
Biotechnology12
Analysis of biological materials4
Computer technology3
Pharmaceuticals1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name11 counted
ProteinSimple a subsidiary
US, as the owner printed on each patent
33 granted
32 published
ASURAGEN, INC. a subsidiary
US, as the owner printed on each patent
31 granted
29 published
BIO-TECHNE CORPORATION its own name
named as the applicant on its applications, in US
0 granted
24 published
ADVANCED CELL DIAGNOSTICS, INC. a subsidiary
named as the applicant on its applications, in US
0 granted
23 published
ADVANCED CELL DIAGNOSTICS, INC. a subsidiary
US, as the owner printed on each patent
7 granted
13 published
CYVEK, INC. a subsidiary
US, as the owner printed on each patent
18 granted
2 published
CyVek, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
16 published
Asuragen, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
14 published
BIO-TECHNE CORPORATION its own name
US, as the owner printed on each patent
12 granted
1 published
ProteinSimple a subsidiary
named as the applicant on its applications, in US
0 granted
11 published
Techne Corporation a former name
US, as the owner printed on each patent
6 granted
0 published
Names not counted (2)
TECHNE CORP /MN/
Most of its patents print IT; this name counts in US. 2 granted and 1 published under it are not counted.
TECHNE CORP /MN/
Most of its patents print IT; this name counts in US. 1 granted and 0 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
Newest applications publishedan application is a clue, never a plan
What it applied for, 2024 to 2025: Measurement 11 · Biotechnology 9 · Analysis of biological materials 3 · Computer technology 2.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton TECH · research, not advice